Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Giuseppe Derosa, Giovanni Gaudio, Gianfranco Pasini, Angela D’Angelo & Pamela Maffioli. (2018) A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients. Drug Design, Development and Therapy 12, pages 2611-2616.
Read now
Read now
Articles from other publishers (3)
Jessica R. Ivy & Matthew A. Bailey. (2021) Nondipping Blood Pressure: Predictive or Reactive Failure of Renal Sodium Handling?. Physiology 36:1, pages 21-34.
Crossref
Crossref
Lakshmanan Loganathan, Krishnasamy Gopinath, Vadivel Murugan Sankaranarayanan, Ritushree Kukreti, Kannan Rajendran, Jung-Kul Lee & Karthikeyan Muthusamy. (2019) Computational and Pharmacogenomic Insights on Hypertension Treatment: Rational Drug Design and Optimization Strategies. Current Drug Targets 21:1, pages 18-33.
Crossref
Crossref
Giuseppe Derosa, Pamela Maffioli, Laura Scelsi, Alessandro Bestetti, Massimo Vanasia, Arrigo F.G. Cicero, Luca Spinardi, Crescenzio Bentivenga, Daniela Degli Esposti, Massimiliano Caprio, Claudio Borghi, Bertram Pitt & Eugenio Cosentino. (2019) Canrenone on cardiovascular mortality in congestive heart failure. Pharmacological Research 141, pages 46-52.
Crossref
Crossref